Ephrin receptor type-A2 (EphA2) targeting in cancer: a patent review (2018-present)
{{output}}
Introduction: EphA2 is a tyrosine kinase receptor and is considered a promising target in cancer. Different approaches are used to target EphA2 receptor, and a lot of preclinical data demonstrate the potential exploitation of thi... ...